OCULAR ABSORPTION FOLLOWING TOPICAL DELIVERY

被引:269
作者
JARVINEN, K
JARVINEN, T
URTTI, A
机构
[1] KUOPIO UNIV,DEPT PHARMACEUT,KUOPIO,FINLAND
[2] KUOPIO UNIV,DEPT PHARMACEUT CHEM,KUOPIO,FINLAND
[3] UNIV CALIF SAN FRANCISCO,SCH PHARM,SAN FRANCISCO,CA 94143
关键词
OPHTHALMIC DRUG; DRUG DELIVERY; OCULAR ABSORPTION; CYCLODEXTRIN; OCULAR PHARMACOKINETICS; CORNEAL PERMEABILITY;
D O I
10.1016/0169-409X(95)00010-5
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Most ocular diseases are treated with topical application of eyedrops. After instillation of an eyedrop, typically less than 5% of the applied drug penetrates the cornea and reaches intraocular tissues, while a major fraction of the instilled dose is absorbed and enters the systemic circulation. Ocular absorption of topically applied ophthalmic drugs is limited by rapid precorneal drug elimination due to solution drainage and systemic absorption from the conjunctival sac. Another factor that limits ocular absorption is the corneal epithelial barrier. In the eye drugs are distributed from the aqueous humor to intraocular tissues and eliminated mainly via aqueous humor turnover and venous blood flow in the anterior uvea. Because of the publication of several reviews [1-3] on ocular drug absorption this review will focus on the most recent literature.
引用
收藏
页码:3 / 19
页数:17
相关论文
共 170 条
  • [41] GRASS GM, 1985, INVEST OPHTH VIS SCI, V26, P110
  • [42] TREATMENT OF DISEASES OF THE EYE WITH MUCOADHESIVE DELIVERY SYSTEMS
    GREAVES, JL
    WILSON, CG
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 1993, 11 (03) : 349 - 383
  • [43] EFFECTS OF CALCIUM-CHANNEL BLOCKERS ON RABBIT CORNEAL ENDOTHELIAL FUNCTION
    GREEN, K
    CHEEKS, L
    HULL, DS
    [J]. CURRENT EYE RESEARCH, 1994, 13 (06) : 401 - 408
  • [44] Grove J, 1990, 5 INT S CYCL PAR ED, P479
  • [45] STRUCTURE, BIOCHEMISTRY, AND ASSEMBLY OF EPITHELIAL TIGHT JUNCTIONS
    GUMBINER, B
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY, 1987, 253 (06): : C749 - C758
  • [46] IDENTIFICATION OF A 160-KDA POLYPEPTIDE THAT BINDS TO THE TIGHT JUNCTION PROTEIN-ZO-1
    GUMBINER, B
    LOWENKOPF, T
    APATIRA, D
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (08) : 3460 - 3464
  • [47] GURNY R, 1987, Journal of Controlled Release, V6, P367, DOI 10.1016/0168-3659(87)90090-3
  • [48] PENETRATION ENHANCEMENT FOR POLYPEPTIDES THROUGH EPITHELIA .D. ROUTES OF DELIVERY - CASE-STUDIES .7. OCULAR DELIVERY OF PEPTIDE AND PROTEIN DRUGS
    HARRIS, D
    LIAW, JH
    ROBINSON, JR
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 1992, 8 (2-3) : 331 - 339
  • [49] CONJUNCTIVAL PENETRATION OF INSULIN AND PEPTIDE DRUGS IN THE ALBINO RABBIT
    HAYAKAWA, E
    CHIEN, DS
    INAGAKI, K
    YAMAMOTO, A
    WANG, W
    LEE, VHL
    [J]. PHARMACEUTICAL RESEARCH, 1992, 9 (06) : 769 - 775
  • [50] HILL JM, 1993, OPHTHALMIC DRUG DELI, P331